메뉴 건너뛰기




Volumn 91, Issue 1-2, 2010, Pages 38-41

Oxidized phosphatidylcholine stimulates activity of secretory phospholipase A2 group IIA and abolishes sphingomyelin-induced inhibition of the enzyme

Author keywords

Activity; Oxidized phosphatidylcholine; Regulation; Secretory phospholipase A2; Sphingomyelin

Indexed keywords

LIPOSOME; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2 GROUP II; SPHINGOMYELIN;

EID: 74849137719     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2009.12.004     Document Type: Article
Times cited : (12)

References (20)
  • 1
    • 58549118043 scopus 로고    scopus 로고
    • Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: the epidemiological evidence
    • Koenig W., and Khuseyinova N. Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: the epidemiological evidence. Cardiovasc Drugs Ther 23 1 (2009) 85-92
    • (2009) Cardiovasc Drugs Ther , vol.23 , Issue.1 , pp. 85-92
    • Koenig, W.1    Khuseyinova, N.2
  • 2
    • 72949102004 scopus 로고    scopus 로고
    • Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease
    • Koenig W., Vossen C.Y., Mallat Z., Brenner H., Benessiano J., and Rothenbacher D. Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease. Eur Heart J 30 22 (2009) 2742-2748
    • (2009) Eur Heart J , vol.30 , Issue.22 , pp. 2742-2748
    • Koenig, W.1    Vossen, C.Y.2    Mallat, Z.3    Brenner, H.4    Benessiano, J.5    Rothenbacher, D.6
  • 3
    • 58549103715 scopus 로고    scopus 로고
    • Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease
    • Rosenson R.S. Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease. Cardiovasc Drugs Ther 23 1 (2009) 93-101
    • (2009) Cardiovasc Drugs Ther , vol.23 , Issue.1 , pp. 93-101
    • Rosenson, R.S.1
  • 4
    • 70350022227 scopus 로고    scopus 로고
    • Opposite effects of native and oxidized lipoproteins on the activity of secretory phospholipase A(2) group IIA
    • Korotaeva A.A., Samoilova E.V., Pirkova A.A., et al. Opposite effects of native and oxidized lipoproteins on the activity of secretory phospholipase A(2) group IIA. Prostaglandins Lipid Mediat 90 1-2 (2009) 37-41
    • (2009) Prostaglandins Lipid Mediat , vol.90 , Issue.1-2 , pp. 37-41
    • Korotaeva, A.A.1    Samoilova, E.V.2    Pirkova, A.A.3
  • 5
    • 84863495004 scopus 로고    scopus 로고
    • The role of oxidized phospholipids in atherosclerosis
    • Berliner J.A., Leitinger N., and Tsimikas S. The role of oxidized phospholipids in atherosclerosis. J Lipid Res 50 Suppl. (2009) S207-S212
    • (2009) J Lipid Res , vol.50 , Issue.SUPPL
    • Berliner, J.A.1    Leitinger, N.2    Tsimikas, S.3
  • 6
    • 59449096216 scopus 로고    scopus 로고
    • Novel aspects of oxidative stress in cardiovascular diseases
    • Heistad D.D., Wakisaka Y., Miller J., Chu Y., and Pena-Silva R. Novel aspects of oxidative stress in cardiovascular diseases. Circ J 73 2 (2009) 201-207
    • (2009) Circ J , vol.73 , Issue.2 , pp. 201-207
    • Heistad, D.D.1    Wakisaka, Y.2    Miller, J.3    Chu, Y.4    Pena-Silva, R.5
  • 7
    • 28444431551 scopus 로고    scopus 로고
    • Oxidized phospholipids as triggers of inflammation in atherosclerosis
    • Leitinger N. Oxidized phospholipids as triggers of inflammation in atherosclerosis. Mol Nutr Food Res 49 11 (2005) 1063-1071
    • (2005) Mol Nutr Food Res , vol.49 , Issue.11 , pp. 1063-1071
    • Leitinger, N.1
  • 8
    • 62349112779 scopus 로고    scopus 로고
    • Oxidized phospholipids in control of inflammation and endothelial barrier
    • Fu P., and Birukov K.G. Oxidized phospholipids in control of inflammation and endothelial barrier. Transl Res 153 4 (2009) 166-176
    • (2009) Transl Res , vol.153 , Issue.4 , pp. 166-176
    • Fu, P.1    Birukov, K.G.2
  • 9
    • 63649134360 scopus 로고    scopus 로고
    • Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration
    • Cherepanova O.A., Pidkovka N.A., Sarmento O.F., et al. Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration. Circ Res 104 5 (2009) 609-618
    • (2009) Circ Res , vol.104 , Issue.5 , pp. 609-618
    • Cherepanova, O.A.1    Pidkovka, N.A.2    Sarmento, O.F.3
  • 10
    • 0037064036 scopus 로고    scopus 로고
    • A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions
    • Podrez E.A., Poliakov E., Shen Z., et al. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J Biol Chem 277 41 (2002) 38517-38523
    • (2002) J Biol Chem , vol.277 , Issue.41 , pp. 38517-38523
    • Podrez, E.A.1    Poliakov, E.2    Shen, Z.3
  • 11
    • 66149131879 scopus 로고    scopus 로고
    • Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial
    • Fraley A.E., Schwartz G.G., Olsson A.G., et al. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial. J Am Coll Cardiol 53 23 (2009) 2186-2196
    • (2009) J Am Coll Cardiol , vol.53 , Issue.23 , pp. 2186-2196
    • Fraley, A.E.1    Schwartz, G.G.2    Olsson, A.G.3
  • 12
    • 33751171875 scopus 로고    scopus 로고
    • Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease
    • Tsimikas S. Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease. Am J Cardiol 98 11A (2006) 9P-17P
    • (2006) Am J Cardiol , vol.98 , Issue.11 A
    • Tsimikas, S.1
  • 13
    • 66549106094 scopus 로고    scopus 로고
    • Oxidized LDL, lipoprotein (a) and other emergent risk factors in acute myocardial infarction (FORTIAM study)
    • Gomez M., Valle V., Aros F., et al. Oxidized LDL, lipoprotein (a) and other emergent risk factors in acute myocardial infarction (FORTIAM study). Rev Esp Cardiol 62 4 (2009) 373-382
    • (2009) Rev Esp Cardiol , vol.62 , Issue.4 , pp. 373-382
    • Gomez, M.1    Valle, V.2    Aros, F.3
  • 14
    • 0030883811 scopus 로고    scopus 로고
    • Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI
    • Koumanov K., Wolf C., and Bereziat G. Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI. Biochem J 326 Pt 1 (1997) 227-233
    • (1997) Biochem J , vol.326 , Issue.PART 1 , pp. 227-233
    • Koumanov, K.1    Wolf, C.2    Bereziat, G.3
  • 15
  • 16
    • 33750933123 scopus 로고    scopus 로고
    • The interfacial binding surface of phospholipase A2s
    • Winget J.M., Pan Y.H., and Bahnson B.J. The interfacial binding surface of phospholipase A2s. Biochim Biophys Acta 1761 11 (2006) 1260-1269
    • (2006) Biochim Biophys Acta , vol.1761 , Issue.11 , pp. 1260-1269
    • Winget, J.M.1    Pan, Y.H.2    Bahnson, B.J.3
  • 17
    • 0037073750 scopus 로고    scopus 로고
    • Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2
    • Singer A.G., Ghomashchi F., Le Calvez C., et al. Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2. J Biol Chem 277 50 (2002) 48535-48549
    • (2002) J Biol Chem , vol.277 , Issue.50 , pp. 48535-48549
    • Singer, A.G.1    Ghomashchi, F.2    Le Calvez, C.3
  • 18
    • 0030742997 scopus 로고    scopus 로고
    • Minimal oxidation and storage of low density lipoproteins result in an increased susceptibility to phospholipid hydrolysis by phospholipase A2
    • Eckey R., Menschikowski M., Lattke P., and Jaross W. Minimal oxidation and storage of low density lipoproteins result in an increased susceptibility to phospholipid hydrolysis by phospholipase A2. Atherosclerosis 132 2 (1997) 165-176
    • (1997) Atherosclerosis , vol.132 , Issue.2 , pp. 165-176
    • Eckey, R.1    Menschikowski, M.2    Lattke, P.3    Jaross, W.4
  • 19
    • 0031785119 scopus 로고    scopus 로고
    • Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL
    • Pruzanski W., Stefanski E., de Beer F.C., et al. Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL. J Lipid Res 39 11 (1998) 2150-2160
    • (1998) J Lipid Res , vol.39 , Issue.11 , pp. 2150-2160
    • Pruzanski, W.1    Stefanski, E.2    de Beer, F.C.3
  • 20
    • 30944447092 scopus 로고    scopus 로고
    • Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis
    • Kougias P., Chai H., Lin P.H., Lumsden A.B., Yao Q., and Chen C. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit 12 1 (2006) RA5-RA16
    • (2006) Med Sci Monit , vol.12 , Issue.1
    • Kougias, P.1    Chai, H.2    Lin, P.H.3    Lumsden, A.B.4    Yao, Q.5    Chen, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.